Literature DB >> 26747301

The combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice.

Andrés Ciudad-Roberts1, Leticia Duart-Castells1, Jorge Camarasa1, David Pubill2, Elena Escubedo1.   

Abstract

A new family of psychostimulants, under the name of cathinones, has broken into the market in the last decade. In light of the fact that around 95% of cathinone consumers have been reported to combine them with alcoholic drinks, we sought to study the consequences of the concomitant administration of ethanol on mephedrone -induced neurotoxicity. Adolescent male Swiss-CD1 mice were administered four times in one day, every 2h, with saline, mephedrone (25mg/kg), ethanol (2; 1.5; 1.5; 1g/kg) and their combination at a room temperature of 26±2°C. The combination with ethanol impaired mephedrone-induced decreases in dopamine transporter and tyrosine hydroxylase in the frontal cortex; and in serotonin transporter and tryptophan hydroxylase in the hippocampus by approximately 2-fold, 7days post-treatment. Furthermore, these decreases correlated with a 2-fold increase in lipid peroxidation, measured as concentration of malondialdehyde (MDA), 24h post-treatment, and were accompanied by changes in oxidative stress-related enzymes. Ethanol also notably potentiated mephedrone-induced negative effects on learning and memory, as well as hippocampal neurogenesis, measured through the Morris water maze (MWM) and 5-bromo-2'-deoxyuridine staining, respectively. These results are of special significance, since alcohol is widely co-abused with amphetamine derivatives such as mephedrone, especially during adolescence, a crucial stage in brain maturation. Given that the hippocampus is greatly involved in learning and memory processes, normal brain development in young adults could be affected with permanent behavioral consequences after this type of drug co-abuse.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescence; Alcohol; Cathinones; Mephedrone; Neurogenesis; Neurotoxicity

Mesh:

Substances:

Year:  2015        PMID: 26747301     DOI: 10.1016/j.taap.2015.12.019

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

Review 1.  Psychoactive Bath Salts and Neurotoxicity Risk.

Authors:  Beril Altun; İsmet Çok
Journal:  Turk J Pharm Sci       Date:  2020-04-24

2.  Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats.

Authors:  Raúl López-Arnau; Mario Buenrostro-Jáuregui; Jorge Camarasa; David Pubill; Elena Escubedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-18       Impact factor: 3.000

Review 3.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

Review 4.  DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Authors:  Steven J Simmons; Jonna M Leyrer-Jackson; Chicora F Oliver; Callum Hicks; John W Muschamp; Scott M Rawls; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

5.  Mephedrone and Alcohol Interactions in Humans.

Authors:  Esther Papaseit; Clara Pérez-Mañá; Elizabeth B de Sousa Fernandes Perna; Eulalia Olesti; Julian Mateus; Kim Pc Kuypers; Eef L Theunissen; Francina Fonseca; Marta Torrens; Jan G Ramaekers; Rafael de la Torre; Magí Farré
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

6.  The Effects of Exposure to Mephedrone During Adolescence on Brain Neurotransmission and Neurotoxicity in Adult Rats.

Authors:  Katarzyna Kamińska; Karolina Noworyta-Sokołowska; Anna Górska; Joanna Rzemieniec; Agnieszka Wnuk; Adam Wojtas; Grzegorz Kreiner; Małgorzata Kajta; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2018-04-30       Impact factor: 3.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.